| http://www.w3.org/ns/prov#value | - But Monsanto argues that if Bowman wins, the decision could render future innovation in a variety of easily replicable technologies ??? including cell lines, DNA molecules, and nanotechnologies ??? economically unfeasible, as biotech firms, universities, and other institutions engaged in research and development would be unable to rely on the patent system to protect against unauthorized copying
|
